Nautilus Biotechnology (NAUT) News
NASDAQ: NAUTIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
2.12-0.05 (-2.30%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
NAUT news summary
We found 4 recent headlines mentioning Nautilus Biotechnology (NAUT): 0 in the past week and 3 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, NAUT is down 2.30% at $2.12. The most recent story, "Nautilus (NAUT) Q3 2026 Earnings Call Transcript", was published by Nasdaq on Oct 27, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Nautilus Biotechnology headlines
- Nautilus (NAUT) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- Nautilus Biotechnology Reports Third Quarter 2026 Financial ResultsSEATTLE, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the…GlobeNewswire
- Nautilus to Measure Proteoforms Driving Alzheimer’s Disease and Cancer in ARPA-H-Funded SEEDS ConsortiumNautilus expects to receive up to $6 million to bring its Voyager™ Platform to a multidisciplinary team integrating protein science, AI, and computational modeling to develop new diagnostics and…GlobeNewswire
- Nautilus Biotechnology to Announce Third Quarter 2026 Financial Results on October 27, 2026SEATTLE, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report…GlobeNewswire